.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Dow
Cerilliant
Baxter
Daiichi Sankyo
Moodys
Express Scripts
Deloitte
QuintilesIMS
US Army

Generated: November 19, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 090913

« Back to Dashboard
NDA 090913 describes MESNA, which is a drug marketed by Fresenius Kabi Usa, Sagent Pharms, West-ward Pharms Int, Mylan Labs Ltd, Teva Pharms Usa, and Mylan Institutional, and is included in six NDAs. It is available from four suppliers. Additional details are available on the MESNA profile page.

The generic ingredient in MESNA is mesna. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the mesna profile page.

Summary for 090913

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Pharmacology for NDA: 090913

Medical Subject Heading (MeSH) Categories for 090913

Suppliers and Packaging for NDA: 090913

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
MESNA
mesna
INJECTABLE;INTRAVENOUS 090913 ANDA Sagent Pharmaceuticals 25021-201 25021-201-68 1 VIAL in 1 CARTON (25021-201-68) > 10 mL in 1 VIAL
MESNA
mesna
INJECTABLE;INTRAVENOUS 090913 ANDA Sagent Pharmaceuticals 25021-201 25021-201-69 10 VIAL in 1 CARTON (25021-201-69) > 10 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INTRAVENOUSStrength100MG/ML
Approval Date:Apr 13, 2010TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Queensland Health
Farmers Insurance
Boehringer Ingelheim
Citi
QuintilesIMS
Dow
UBS
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot